April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Bromfenac for the Treatment of Chronic Pseudophakic Cystoid Macular Edema
Author Affiliations & Notes
  • E. F. Kadrmas
    Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  E.F. Kadrmas, ISTA Pharmaceuticals, F.
  • Footnotes
    Support  Unrestricted research grant --ISTA Pharmaceuticals
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1345. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. F. Kadrmas; Bromfenac for the Treatment of Chronic Pseudophakic Cystoid Macular Edema. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1345.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the potential role of bromfenac in the treatment of chronic pseudophakic cystoid macular edema (CME).

Methods: : Retrospective clinical and optical coherence tomography (OCT) analysis of 11 consecutive cases of CME unresponsive to treatment with ketorolac 0.4% q.i.d. following cataract surgery subsequently treated with bromfenac 0.09% b.i.d. as a single agent.

Results: : All 11 eyes treated with bromfenac showed complete clinical resolution of the CME with average visual improvement of 12.7 Snellen letters (S.E.M. 3.8 letters). All eyes showed complete resolution of macular edema by OCT line study analysis. The average decrease in central macular thickness and central macular volume measured 58.3 microns (S.E.M. 17.6 microns) and 0.18 mm3 (S.E.M. 0.05 mm3) respectively. Length of treatment with bromfenac averaged 20.1 weeks (Range: 10-40 weeks). Prior length of treatment with ketorolac averaged 23.0 weeks (Range: 9-50 weeks).

Conclusions: : Bromfenac appears to be effective in the treatment of pseudophakic CME in cases refractory to treatment with ketorolac. Length of treatment is variable and may need to be prolonged to achieve the desired clinical outcome.

Keywords: retina • edema • inflammation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.